A new trading day began on Friday, with Tarsus Pharmaceuticals Inc (NASDAQ: TARS) stock price up 6.32% from the previous day of trading, before settling in for the closing price of $44.49. TARS’s price has ranged from $13.91 to $46.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -17.43%. Meanwhile, its annual earnings per share averaged 17.88%. With a float of $31.79 million, this company’s outstanding shares have now reached $34.21 million.
Let’s determine the extent of company efficiency that accounts for 244 employees. In terms of profitability, gross margin is 92.5%, operating margin of -187.55%, and the pretax margin is -182.14%.
Tarsus Pharmaceuticals Inc (TARS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tarsus Pharmaceuticals Inc is 16.42%, while institutional ownership is 100.27%. The most recent insider transaction that took place on Aug 12 ’24, was worth 912,961. In this transaction Director of this company sold 35,000 shares at a rate of $26.08, taking the stock ownership to the 0 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Director proposed sale 35,000 for $26.85, making the entire transaction worth $939,750.
Tarsus Pharmaceuticals Inc (TARS) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.28 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.95 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.88% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Here are Tarsus Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.48, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -2.16 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Looking closely at Tarsus Pharmaceuticals Inc (NASDAQ: TARS), its last 5-days average volume was 1.44 million, which is a jump from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 83.66%. Additionally, its Average True Range was 2.28.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 95.44%, which indicates a significant increase from 89.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.93% in the past 14 days, which was lower than the 63.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.94, while its 200-day Moving Average is $31.79. However, in the short run, Tarsus Pharmaceuticals Inc’s stock first resistance to watch stands at $49.02. Second resistance stands at $50.73. The third major resistance level sits at $52.87. If the price goes on to break the first support level at $45.17, it is likely to go to the next support level at $43.03. Should the price break the second support level, the third support level stands at $41.32.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
With a market capitalization of 1.91 billion, the company has a total of 38,042K Shares Outstanding. Currently, annual sales are 17,450 K while annual income is -135,890 K. The company’s previous quarter sales were 40,810 K while its latest quarter income was -33,290 K.
